Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Stock Surges 8.4 Percent One Day After CEO Gobbles Up 200,000 Shares

NEW YORK, Nov. 22 (GenomeWeb News) - Shares in Bruker BioSciences were up 8.4 percent at $4.27 in mid-afternoon trading after CEO Frank Laukien spent five days buying $781,000 worth of Bruker stock.

 

Laukien ended the buying spree last Friday with 200,000 additional shares in his portfolio, according to the website  www.insidercow.com.


Bruker has around 89.5 million shares outstanding and currently has a market capitalization of approximately $382 million.

 

A company spokesman confirmed the purchases.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.